Concerns About Childhood COVID-19 Vaccines Persist, Despite FDA Committee OK

October 28th 2021

Some have expressed concerns about the risk of myocarditis and unknown longer-term side effects.

Generic of Decadron is Launched to Treat COVID-19

October 28th 2021

Dexamethasone is recommended by the NIH and the World Health Organization for treating COVID-19.

Segal: Specialty Drugs Driving Cost Trend

October 27th 2021

Specialty drug prices are rising as these therapeutics replace lower-cost therapies.

FDA Accepts Novartis’ Application for New Indication for Kymriah

October 27th 2021

Novatis is seeking approval for Kymriah in adult patients with advanced follicular lymphoma.

FDA Advisory Committee Recommends Pfizer Vaccine for Children

October 27th 2021

The phase 2/3 trial showed a favorable safety profile, robust immune responses and a vaccine efficacy rate of 90.7% in children 5 to 11 years of age.